In particular, we analyse, across multiple cancer types, the genomic landscape of S-CIN and W-CIN, their relationship to prognosis and drug sensitivity, the relationship between CIN, somatic point mutations and specific copy number variations and propose a new link between S-CIN and the PI3K oncogenic pathway. This evidence concerns the gene PIK3CA and cancer.